These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25792730)

  • 1. Speaking a common language in MDS/MPNs.
    Steensma DP
    Blood; 2015 Mar; 125(12):1849-51. PubMed ID: 25792730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults.
    Savona MR; Malcovati L; Komrokji R; Tiu RV; Mughal TI; Orazi A; Kiladjian JJ; Padron E; Solary E; Tibes R; Itzykson R; Cazzola M; Mesa R; Maciejewski J; Fenaux P; Garcia-Manero G; Gerds A; Sanz G; Niemeyer CM; Cervantes F; Germing U; Cross NC; List AF;
    Blood; 2015 Mar; 125(12):1857-65. PubMed ID: 25624319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing specific response criteria for MDS/MPN - Getting closer to reality?
    Villaume MT; Savona MR
    Best Pract Res Clin Haematol; 2020 Jun; 33(2):101170. PubMed ID: 32460975
    [No Abstract]   [Full Text] [Related]  

  • 4. MDS overlap disorders and diagnostic boundaries.
    Tanaka TN; Bejar R
    Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelodysplastic/myeloproliferative disorders.
    Malcovati L; Cazzola M
    Haematologica; 2008 Jan; 93(1):4-6. PubMed ID: 18166777
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes?
    Padron E
    Hematology Am Soc Hematol Educ Program; 2015; 2015():349-54. PubMed ID: 26637742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topics in pediatric leukemia--myelodysplastic and myeloproliferative disorders of childhood.
    Lasky J; Sakamoto KM
    MedGenMed; 2005 Mar; 7(1):21. PubMed ID: 16369326
    [No Abstract]   [Full Text] [Related]  

  • 8. Traipsing Through Muddy Waters: A Critical Review of the Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes.
    Kuykendall AT; Tokumori FC; Komrokji RS
    Hematol Oncol Clin North Am; 2021 Apr; 35(2):337-352. PubMed ID: 33641873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Challenge of Treating Myelodysplastic Syndromes/Myeloproliferative Neoplasms.
    Ragon BK; Savona MR
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S37-S42. PubMed ID: 28760301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing Symptom Burden in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Patients.
    Garza J; Anderson JM; Scherber RM
    Hematol Oncol Clin North Am; 2020 Apr; 34(2):475-489. PubMed ID: 32089224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D insufficiency in myeloproliferative neoplasms and myelodysplastic syndromes: clinical correlates and prognostic studies.
    Pardanani A; Drake MT; Finke C; Lasho TL; Rozell SA; Jimma T; Tefferi A
    Am J Hematol; 2011 Dec; 86(12):1013-6. PubMed ID: 22086864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials.
    Platzbecker U; Fenaux P; Adès L; Giagounidis A; Santini V; van de Loosdrecht AA; Bowen D; de Witte T; Garcia-Manero G; Hellström-Lindberg E; Germing U; Stauder R; Malcovati L; Sekeres MA; Steensma DP; Gloaguen S
    Blood; 2019 Mar; 133(10):1020-1030. PubMed ID: 30404811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders.
    Bain BJ
    Leuk Lymphoma; 1999 Aug; 34(5-6):443-9. PubMed ID: 10492067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
    Harada Y; Harada H
    Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report.
    Tefferi A; Cervantes F; Mesa R; Passamonti F; Verstovsek S; Vannucchi AM; Gotlib J; Dupriez B; Pardanani A; Harrison C; Hoffman R; Gisslinger H; Kröger N; Thiele J; Barbui T; Barosi G
    Blood; 2013 Aug; 122(8):1395-8. PubMed ID: 23838352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is survival in myeloid malignancies really improving? A retrospective 15-year population-based study.
    Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Guàrdia R; Marcos-Gragera R
    Leuk Lymphoma; 2015 Apr; 56(4):896-902. PubMed ID: 25058372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO.
    Kuykendall AT; Padron E
    Curr Hematol Malig Rep; 2019 Dec; 14(6):543-549. PubMed ID: 31776774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.
    Sharma P; Shinde SS; Damlaj M; Hefazi Rorghabeh M; Hashmi SK; Litzow MR; Hogan WJ; Gangat N; Elliott MA; Al-Kali A; Tefferi A; Patnaik MM
    Leuk Lymphoma; 2017 Apr; 58(4):872-881. PubMed ID: 27687869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making sense of the myelodysplastic/myeloproliferative neoplasms overlap syndromes.
    Tiu RV; Sekeres MA
    Curr Opin Hematol; 2014 Mar; 21(2):131-40. PubMed ID: 24378705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies.
    Gorak EJ; Otterstatter M; Al Baghdadi T; Gillis N; Foran JM; Liu JJ; Bejar R; Gore SD; Kroft SH; Harrington A; Saber W; Starczynowski D; Rollison DE; Zhang L; Moscinski L; Wilson S; Thompson J; Borchert C; Sherman S; Hebert D; Walker ME; Padron E; DeZern AE; Sekeres MA
    Blood Adv; 2023 Oct; 7(20):6120-6129. PubMed ID: 37552083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.